Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 5S ribosomal pseudogene 132 (RNA5SP132) is a human pseudogene classified in the 5S ribosomal RNA gene family[2]. Pseudogenes are non-functional genomic sequences that resemble functional genes but typically acquire mutations preventing normal transcription, translation, or gene product function[4]. RNA5SP132 is not known to encode a protein or functional RNA; instead, it represents a processed or unprocessed pseudogene derived from an ancestral 5S rRNA gene. While some pseudogenes have been shown to regulate gene networks or parental gene expression through antisense transcription or interactions with RNA-binding proteins, no specific functional, therapeutic, or pathological roles have been documented for RNA5SP132[4]. It is not a drug target, receptor, enzyme, transporter, or regulatory protein, and no direct clinical associations, biomarkers, or safety issues are linked to this pseudogene[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 5S ribosomal pseudogene 132 (RNA5SP132).